J Radl
Overview
Explore the profile of J Radl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
167
Citations
1766
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haaijman J, Deen C, Krose C, Zijlstra J, Coolen J, Radl J
Immunol Today
. 2014 Oct;
5(3):56-8.
PMID: 25291508
No abstract available.
2.
Vancikova Z, Lodinova-Zadnikova R, Radl J, Tlaskalova-Hogenova H
Folia Microbiol (Praha)
. 2003 Jun;
48(2):281-7.
PMID: 12800517
The development of levels of secretory immunoglobulins (SIgs) in newborns' saliva was examined under physiological conditions and after artificial colonization with nonpathogenic, probiotic bacterial strain E. coli O83. Higher levels...
3.
Asosingh K, Radl J, Van Riet I, Van Camp B, Vanderkerken K
Hematol J
. 2002 Mar;
1(5):351-6.
PMID: 11920212
No abstract available.
4.
Stevenson F, King C, Spellerberg M, Zhu D, Rice J, Sahota S, et al.
Haematologica
. 2000 Jul;
84 Suppl EHA-4:11-3.
PMID: 10907456
DNA vaccines against cancer have to activate an inadequate or damaged immune system in order to attack residual cancer cells. Although the potential problem of tolerance may be overcome by...
5.
Radl J
Pathol Biol (Paris)
. 1999 Apr;
47(2):109-14.
PMID: 10192877
This short review of our own work presents two aspects of the studies on multiple myeloma (MM) in an animal model--the aging C57BL/KaLwRij mouse: 1. the immunological/biological aspect of the...
6.
Dallas S, Garrett I, Oyajobi B, Dallas M, Boyce B, Bauss F, et al.
Blood
. 1999 Feb;
93(5):1697-706.
PMID: 10029599
We determined the effects of the potent bisphosphonate ibandronate in a murine model of human myeloma bone disease. In this model, bone lesions typical of the human disease develop in...
7.
King C, Spellerberg M, Zhu D, Rice J, Sahota S, Thompsett A, et al.
Nat Med
. 1998 Nov;
4(11):1281-6.
PMID: 9809552
Vaccination with idiotypic protein protects against B-cell lymphoma, mainly through anti-idiotypic antibody. For use in patients, DNA vaccines containing single-chain Fv derived from tumor provide a convenient alternative vaccine delivery...
8.
Zhu D, van ARKEL C, King C, Meirvenne S, de Greef C, Thielemans K, et al.
Immunology
. 1998 Jun;
93(2):162-70.
PMID: 9616364
The 5T series of multiple myelomas (MM) and Waldenstrsöm's macroglobulinaemia-like lymphomas (WM), which developed spontaneously in ageing mice of the C57BL/KaLwRij strain, shows clinical and biological features that closely resemble...
9.
van ARKEL C, Hopstaken C, Zurcher C, Bos N, Kroese F, Savelkoul H, et al.
Eur J Immunol
. 1997 Oct;
27(9):2436-40.
PMID: 9341790
Monoclonal gammopathies (MG) are monoclonal proliferative disorders of B cells at the differentiation stage of Ig production. They can be detected in the serum, either as transient or as persistent...
10.
Tomana M, Matousovic K, Julian B, Radl J, Konecny K, Mestecky J
Kidney Int
. 1997 Aug;
52(2):509-16.
PMID: 9264010
IgA1 proteins from sera of patients with IgA nephropathy (IgAN) are galactosylated to a lesser degree than those from healthy controls. The increased reactivity of intact or de-sialylated serum IgA1...